These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9848448)

  • 1. Toxicity and therapeutic efficacy of amphotericin B delivered through cholesterol hemisuccinate vesicles in the treatment of experimental murine aspergillosis.
    Saxena S; Khan JA; Ghosh PC
    J Antimicrob Chemother; 1998 Nov; 42(5):635-42. PubMed ID: 9848448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodistribution of amphotericin B when delivered through cholesterol hemisuccinate vesicles in normal and A. fumigatus infected mice.
    Saxena S; Ghosh PC
    Pharm Res; 2000 Oct; 17(10):1236-42. PubMed ID: 11145229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacies, toxicities, and tissue concentrations of amphotericin B lipid formulations in a murine pulmonary aspergillosis model.
    Olson JA; Adler-Moore JP; Schwartz J; Jensen GM; Proffitt RT
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2122-31. PubMed ID: 16723574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of amphotericin B-arabinogalactan conjugate in mouse tissue and its therapeutic efficacy against murine aspergillosis.
    Falk R; Grunwald J; Hoffman A; Domb AJ; Polacheck I
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3606-9. PubMed ID: 15328139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of amphotericin B lipid formulation on immune response in aspergillosis.
    Saxena S; Bhatnagar PK; Ghosh PC; Sarma PU
    Int J Pharm; 1999 Oct; 188(1):19-30. PubMed ID: 10528079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental murine aspergillosis. Comparison of amphotericin B and a new polyene antifungal drug, SCH 28191.
    Graybill JR; Kaster SR
    Am Rev Respir Dis; 1984 Feb; 129(2):292-5. PubMed ID: 6364905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A pharmacodynamics study of an intravitreal amphotericin B drug delivery system for the treatment of experimental Aspergillus fumigatus endophthalmitis].
    Yang X; Dong XG; Liu AM; Sun SY; Xie LX; Wang SG
    Zhonghua Yan Ke Za Zhi; 2007 Jun; 43(6):546-53. PubMed ID: 17897534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic and hemolytic evaluation of in-situ liposomal preparation containing amphotericin - beta complexed with different chemically modified beta - cyclodextrins.
    Chakraborty KK; Naik SR
    J Pharm Pharm Sci; 2003; 6(2):231-7. PubMed ID: 12935435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vivo therapeutic efficacy in experimental murine mycoses of a new formulation of deoxycholate-amphotericin B obtained by mild heating.
    Petit C; Chéron M; Joly V; Rodrigues JM; Bolard J; Gaboriau F
    J Antimicrob Chemother; 1998 Dec; 42(6):779-85. PubMed ID: 10052902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of high loading doses of liposomal amphotericin B in the treatment of experimental invasive pulmonary aspergillosis.
    Gavaldà J; Martín T; López P; Gomis X; Ramírez JL; Rodríguez D; Len O; Puigfel Y; Ruiz I; Pahissa A
    Clin Microbiol Infect; 2005 Dec; 11(12):999-1004. PubMed ID: 16307554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the antifungal activity and toxicity profile of amphotericin B lipid complex (ABLC; Abelcet) in combination with caspofungin in experimental systemic aspergillosis.
    Sivak O; Bartlett K; Risovic V; Choo E; Marra F; Batty DS; Wasan KM
    J Pharm Sci; 2004 Jun; 93(6):1382-9. PubMed ID: 15124198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicity and efficacy differences between liposomal amphotericin B formulations in uninfected and Aspergillus fumigatus infected mice.
    Olson JA; Schwartz JA; Hahka D; Nguyen N; Bunch T; Jensen GM; Adler-Moore JP
    Med Mycol; 2015 Feb; 53(2):107-18. PubMed ID: 25550388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D and experimental invasive aspergillosis.
    Sirivoranankul C; Martinez M; Chen V; Clemons KV; Stevens DA
    Med Mycol; 2014 Nov; 52(8):847-52. PubMed ID: 25231772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of SCH51048 in an experimental model of pulmonary aspergillosis.
    Allendoerfer R; Loebenberg D; Rinaldi MG; Graybill JR
    Antimicrob Agents Chemother; 1995 Jun; 39(6):1345-8. PubMed ID: 7574528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro and in-vivo evaluation of a new amphotericin B emulsion-based delivery system.
    Tabosa Do Egito ES; Appel M; Fessi H; Barratt G; Puisieux F; Devissaguet JP
    J Antimicrob Chemother; 1996 Sep; 38(3):485-97. PubMed ID: 8889723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose range evaluation of liposomal nystatin and comparisons with amphotericin B and amphotericin B lipid complex in temporarily neutropenic mice infected with an isolate of Aspergillus fumigatus with reduced susceptibility to amphotericin B.
    Denning DW; Warn P
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2592-9. PubMed ID: 10543734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo resistance of a laboratory-selected Aspergillus fumigatus isolate to amphotericin B.
    Manavathu EK; Cutright JL; Chandrasekar PH
    Antimicrob Agents Chemother; 2005 Jan; 49(1):428-30. PubMed ID: 15616327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of nebulized liposomal amphotericin B in treatment of experimental pulmonary aspergillosis.
    Gavaldà J; Martín MT; López P; Gomis X; Ramírez JL; Rodríguez D; Len O; Puigfel Y; Ruíz I; Pahissa A
    Antimicrob Agents Chemother; 2005 Jul; 49(7):3028-30. PubMed ID: 15980392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-circulating immunoliposomal amphotericin B against invasive pulmonary aspergillosis in mice.
    Otsubo T; Maruyama K; Maesaki S; Miyazaki Y; Tanaka E; Takizawa T; Moribe K; Tomono K; Tashiro T; Kohno S
    Antimicrob Agents Chemother; 1998 Jan; 42(1):40-4. PubMed ID: 9449258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary aspergillosis in mice: treatment with a new triazole SCH39304.
    Defaveri J; Salazar MH; Rinaldi MG; Graybill JR
    Am Rev Respir Dis; 1990 Sep; 142(3):512-5. PubMed ID: 2202244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.